{"id":"W4379280969","doi":"10.1200/jco.2023.41.16_suppl.9008","title":"Biomarker subgroup analyses of CodeBreaK 200, a phase 3 trial of sotorasib versus (vs) docetaxel in patients (pts) with pretreated <i>KRAS</i> G12C-mutated advanced non-small cell lung cancer (NSCLC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre","funders":"Amgen","keywords":"Docetaxel; KRAS; Medicine; Clinical endpoint; Internal medicine; Oncology; Biomarker; Cancer; Lung cancer; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Phases of clinical research; Randomized controlled trial; Clinical trial; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002865546,0.00140961,0.002090703,0.0004086198,0.0003568527,0.001081383,0.0009180642,0.001498526,0.003603173],"category_scores_gemma":[0.002959966,0.0004536585,0.003961723,0.0004681603,0.0004757151,0.0007665221,0.0005689871,0.002091413,0.0003564016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00102998,"about_ca_system_score_gemma":0.001466602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001007779,"about_ca_topic_score_gemma":0.004366898,"domain_scores_codex":[0.9987833,0.0006125002,0.00008361373,0.0002706469,0.0001109805,0.0001390222],"domain_scores_gemma":[0.9982071,0.000599646,0.0003674992,0.0002519698,0.0001120792,0.0004616978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9664647,0.001671438,0.00731014,0.0003703978,0.005794663,0.00009564545,0.00007073712,0.001029878,0.005427678,0.00008177253,0.001659818,0.01002314],"study_design_scores_gemma":[0.6398485,0.2207998,0.1027122,0.00009547833,0.01926534,0.0005202806,0.0001941577,0.005989072,0.003426162,0.00111201,0.005876469,0.0001605996],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930536,0.001869382,0.0003391848,0.0003101045,0.0001504667,0.0008992275,0.002408061,0.00004511471,0.0009247496],"genre_scores_gemma":[0.9912321,0.0004368966,0.000714449,0.0005536699,0.0001231024,0.0009286908,0.004957855,0.00002140972,0.00103175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003603173,"threshold_uncertainty_score":0.01515466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1010531826313901,"score_gpt":0.5176842000167955,"score_spread":0.4166310173854054,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}